New perspectives on enigmatic vanilloid receptors

Trends in Neurosciences

Volumn 23, Issue 10, 2000, Pages 491-497

  Szallasi, Arpad ^a   Di Marzo, Vincenzo ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CNR   (Italy)

Author keywords

Neuroscience

Indexed keywords

ANANDAMIDE; ARVANIL; CANNABINOID RECEPTOR; CAPSAICIN; LIGAND; OLVANIL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

BRAIN FUNCTION; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARACHIDONIC ACIDS; BRAIN CHEMISTRY; CAPSAICIN; DITERPENES; DRUG DESIGN; ENDOCANNABINOIDS; FORECASTING; GANGLIA, SPINAL; GLYCERIDES; HUMANS; LIGANDS; NERVE TISSUE PROTEINS; NEURONS, AFFERENT; POLYUNSATURATED ALKAMIDES; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034307478     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01630-1     Document Type: Review

References (82)

1. Wood J.N. Capsaicin in the Study of Pain. 1993;Academic Press.
2. Szallasi A., Blumberg P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51:1999;159-211.
3. Sterner O., Szallasi A. Novel natural vanilloid receptor agonists: new therapeutic targets for drug development. Trends Pharmacol. Sci. 20:1999;431-469.
4. Caterina M.J.et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 398:1997;816-824.
5. Caterina M.J.et al. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature. 398:1999;436-441.
6. Suzuki M.et al. Cloning of a stretch-inhibitable nonselective cation channel. J. Biol. Chem. 274:1999;6330-6335.
7. Schumacher M.A.et al. Molecular cloning of an N-terminal splice variant of the capsaicin receptor. J. Biol. Chem. 275:2000;2756-2762.
8. Mezey E.et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3655-3660.
9. Wood J.N. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications II. Genetic approaches to pain therapy. Am J. Physiol. 278:2000;G507-G512.
10. Tominaga M.et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21:1998;531-543.
11. Smart D.et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129:2000;227-230.
12. Wardle K.A.et al. Pharmacological characterization of the vanilloid receptor in the rat dorsal horn. Br. J. Pharmacol. 121:1997;1012-1016.
13. Griffiths C.D.et al. Capsaicin-induced biphasic oxygen uptake in rat muscle: antagonism by capsazepine and ruthenium red provides further evidence for peripheral vanilloid receptor subtypes (VN1/VN2). Life Sci. 59:1996;105-107.
14. Szallasi A., Blumberg P.M. Vanilloid receptors: new insights enhance potential as a therapeutic target. Pain. 68:1996;195-208.
15. 45Ca uptake and for high affinity binding in cultured rat dorsal root ganglion neurons and dorsal root ganglion membranes. Mol. Brain Res. 35:1996;173-182.
16. 2+ dependence in rat trigeminal ganglion cells. J. Neurophysiol. 75:1996;1503-1514.
17. Petersen M.et al. Multiple capsaicin-evoked currents in isolated rat sensory neurons. Neuroscience. 75:1996;495-505.
18. Szallasi A.et al. The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol. Pharmacol. 56:1999;581-587.
19. Zygmunt P.M.et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.
20. Di Marzo V.et al. Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett. 436:1998;449-454.
21. Szolcsányi J. Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? Trends Pharmacol. Sci. 21:2000;41-42.
22. Zygmunt P.M.et al. Anandamide - the other side of the coin. Trends Pharmacol. Sci. 21:2000;43-44.
23. Smart D., Jerman J.C. Anandamide: an endogenous activator of the vanilloid receptor. Trends Pharmacol. Sci. 21:2000;134.
24. Matsuda L.A.et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
25. Munro S.et al. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
26. Melck D.et al. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anadamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem. Biophys. Res. Commun. 262:1999;275-284.
27. Devane W.A.et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
28. Mechoulam R.et al. Endocannabinoids. Eur. J. Pharmacol. 359:1998;1-18.
29. Di Marzo V.et al. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
30. Di Marzo V. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuro-modulators. Life Sci. 65:1999;645-655.
31. Martin B.R., Lichtman A.H. Cannabinoid transmission and pain perception. Neurobiol. Dis. 5:1998;447-461.
32. Kunos G.et al. Cardiovascular effects of endocannabinoids - the plot thickens. Prostaglandins Other Lipid Mediat. 61:2000;71-84.
33. Di Marzo, V. et al. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide (arvanil). Eur. J. Pharmacol. (in press).
34. Beltramo M.et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 277:1997;1094-1097.
35. Zygmunt P.M.et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur. J. Pharmacol. 396:2000;39-42.
36. 3 purinoceptor and IB4 binding sites. Eur. J. Neurosci. 11:1999;946-958.
37. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neurosci. 24:1988;739-768.
38. Piper A.S., Docherty R.J. One-way cross-desensitization between P2X purinoceptors and vanilloid receptors in adult rat dorsal root ganglion neurones. J. Physiol. 523:2000;685-696.
39. Michael G.J., Priestley J.V. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J. Neurosci. 19:1999;1844-1854.
40. Holzer P. Sensory neurons in the stomach. Geppetti P., Holzer P. Neurogenic Inflammation. 1996;CRC Press.
41. Liu L., Simon S.A. Similarities and differences in the currents activated by capsaicin, piperine and zingerone in rat trigeminal ganglion cells. J. Neurophysiol. 76:1996;1858-1869.
42. Brand L.et al. NE-19550: a novel, orally active anti-inflammatory analgesic. Drugs Exp. Clin. Res. 13:1987;259-265.
43. Hofmann T.et al. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature. 397:1987;259-263.
44. Chyb S.et al. Polyunsaturated fatty acids activate the Drosophila light-sensitive channels TRP and TRPL. Nature. 397:1999;255-259.
45. Richardson J.D.et al. Antihyperalgesic effects of spinal cannabinoids. Eur. J. Pharmacol. 345:1998;145-153.
46. Farquhar-Smith W.P.et al. Cannabinoid CB1 receptor expression in rat spinal cord. Mol. Cell. Neurosci. 15:2000;510-521.
47. Hohmann A.G., Herkenham M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience. 90:1999;923-931.
48. 2+-induced relaxation. J. Pharmacol. Exp. Ther. 289:1999;245-250.
49. Bisogno T.et al. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem. 272:1997;3315-3323.
50. 1 cannabinoid receptors in haemorrhagic shock. Nature. 390:1997;518-521.
51. Pestonjamasp V.K., Burstein S.H. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim. Biophys. Acta. 1394:1997;249-260.
52. Hwang S.W.et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6155-6160.
53. Rabe L.S.et al. Neurophysiological and thermoregulatory effects of capsaicin. Brain Res. Bull. 5:1980;755-758.
54. Dawbarn D.et al. Intranigral injection of capsaicin enhances motor activity and depletes nigral 5-hydroxytryptamine but not substance P. Neuropharmacology. 20:1981;341-346.
55. Hajós M.et al. Capsaicin-induced excitation of locus coeruleus neurons. Acta Physiol. Scand. 129:1987;415-420.
56. Hajós M.et al. Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum. J. Neural Transm. 74:1988;129-139.
57. Aranda F.et al. Capsaicin affects the structure and phase organization of phospholipid membranes. Biochim. Biophys. Acta. 1234:1988;225-234.
58. Feigin A.M.et al. Capsaicin and its analogs induce ion channels in planar lipid bilayers. NeuroReport. 6:1995;2134-2136.
59. Shimomura Y.et al. Capsaicin and its analogs inhibit the activity of the NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain. Arch. Biochem. Biophys. 270:1989;573-577.
60. Wolvetang E.J.et al. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ. 7:1989;1315-1325.
61. Sasamura T.et al. Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. NeuroReport. 9:1989;2045-2048.
62. Szallasi A.et al. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res. 703:1995;175-183.
63. Jancsó-Gábor A.et al. Stimulation and desensitization of the hypothalamic heat-sensitive structures by capsaicin in rats. J. Physiol. 208:1970;449-459.
64. Szolcsányi J.et al. Mitochondrial changes in preoptic neurones after capsaicin desensitization of the hypothalamic thermodetectors in rats. Nature. 299:1970;116-117.
65. Adams I.B.et al. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther. 284:1998;1209-1217.
66. 1 receptor mRNA in the pituitary gland. Neuroendocrinology. 70:1998;137-145.
67. Herkenham M.et al. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1932-1936.
68. Jancsó G., Wollemann M. The effect of capsaicin on the adenylate cyclase activity of rat brain. Brain Res. 123:1977;323-329.
69. Howlett A.C. Cannabinoid compounds and signal transduction mechanisms. Pertwee R. Cannabinoid Receptors. 1995;Academic Press.
70. Sulcova E.et al. Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59:1998;347-352.
71. Bisogno T.et al. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun. 256:1999;377-380.
72. Meng I.D.et al. An analgesia circuit activated by cannabinoids. Nature. 395:1999;381-383.
73. Walker J.M.et al. Pain modulation by release of the endogenous cannabinoid anandamide. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12198-12203.
74. 1 receptor knockout mice. Science. 283:1999;401-404.
75. 1 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5780-5785.
76. Caterina M.J.et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 288:2000;306-313.
77. Davis J.B.et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 405:2000;183-188.
78. Sharkey L.et al. Mutations in the putative sixth transmembrane domain provide evidence for multimerization of the VR1 receptor. Soc. Neurosci. Abstr. 25:1999;690.
79. Hahn J.H.et al. Ginsenosides inhibit capsaicin channels in rat dorsal root ganglion neurons. Neurosci. Lett. 287:2000;45-48.
80. Lee S.H., Premkumar L.S. Inhibition of capsaicin-induced single channel currents by cocaine. Soc. Neurosci. Abstr. 25:1999;2255.
81. Jordt S-E.et al. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8134-8139.
82. Garcia-Martinez C.et al. Identification of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties. J. Biol. Chem. 2000;. published online ahead of print.